RedHill Biopharma (RDHL) EPS (Weighted Average and Diluted) (2013 - 2022)
RedHill Biopharma (RDHL) reported EPS (Weighted Average and Diluted) of $0.02 for Q2 2022, down 66.67% year-over-year from $0.06 in Q2 2021, and down 66.67% quarter-over-quarter from $0.06 in Q2 2021.
RedHill Biopharma (RDHL) EPS (Weighted Average and Diluted) (2013 - 2022) Analysis & Trends
RedHill Biopharma (RDHL) has 8 years of EPS (Weighted Average and Diluted) data on file, last reported at $0.02 in Q2 2022.
- EPS (Weighted Average and Diluted) for Q2 2022 came in at $0.02, down 66.67% year-over-year; the trailing twelve-month figure through Jun 2022 was $0.19 (up 179.17% YoY), and the FY2023 annual result was $0.01, up 108.33% from the prior year.
- EPS (Weighted Average and Diluted) slipped to $0.02 in Q2 2022 per RDHL's latest filing, from $0.06 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at $0.06 in Q2 2021 and troughed at $0.02 in Q2 2022.
- A 3-year average of $0.04 and a median of $0.05 in 2018 frame the typical range for EPS (Weighted Average and Diluted).
- The sharpest annual moves came in 2018 and 2022: EPS (Weighted Average and Diluted) decreased 16.67% in 2018, then plunged 66.67% in 2022.
- A 3-year view of EPS (Weighted Average and Diluted) shows it stood at $0.05 in 2018, then gained by 20.0% to $0.06 in 2021, then sank by 66.67% to $0.02 in 2022.
- Business Quant data shows RDHL's EPS (Weighted Average and Diluted) at $0.02 in Q2 2022, $0.06 in Q2 2021, and $0.05 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 0.31 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 5.82 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.91 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -0.40 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -0.40 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.80 |
| 10 | RedHill Biopharma | 119.32 Mn | 119.32 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 0.02 |
| Jun 30, 2021 | 0.06 |
| Jun 30, 2018 | 0.05 |
| Jun 30, 2017 | 0.06 |
| Dec 31, 2016 | -0.41 |
| Sep 30, 2016 | 0.07 |
| Jun 30, 2016 | 0.06 |
| Dec 31, 2015 | 0.05 |
| Sep 30, 2015 | 0.04 |
| Jun 30, 2015 | 0.07 |
| Mar 31, 2015 | -0.05 |
| Dec 31, 2014 | 0.06 |
| Sep 30, 2014 | 0.06 |
| Mar 31, 2014 | 0.04 |
| Dec 31, 2013 | 0.05 |
| Sep 30, 2013 | 0.04 |
| Mar 31, 2013 | -0.03 |